These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1387094)

  • 21. Lp(a) lipoprotein: an overview.
    Berg K
    Chem Phys Lipids; 1994 Jan; 67-68():9-16. PubMed ID: 8187248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a).
    Wong WL; Eaton DL; Berloui A; Fendly B; Hass PE
    Clin Chem; 1990 Feb; 36(2):192-7. PubMed ID: 2137383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a), atherosclerosis and thrombosis.
    Dahlén GH
    Prog Lipid Res; 1991; 30(2-3):189-94. PubMed ID: 1840453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
    Lenzi S; Scanu A; De Caterina R
    G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
    Armstrong VW
    Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prospective trends in studies on the role of lipoproteins in human atherogenesis: their effect on disease progression, diagnostic value and the possibility of corrective interventions].
    Perova NV
    Kardiologiia; 1989 Jun; 29(6):5-9. PubMed ID: 2779078
    [No Abstract]   [Full Text] [Related]  

  • 27. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipoprotein(a). Its importance as an additional atherosclerosis marker].
    Campos E
    Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels].
    Safarova MS; Trukhacheva EP; Ezhov MV; Afanas'eva OI; Afanas'eva MI; Tripoten' MI; Liakishev AA; Pokrovskiĭ SN
    Kardiologiia; 2011; 51(5):9-16. PubMed ID: 21649590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
    Scanu AM
    Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.
    Schmitz G; Orsó E
    Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):21-5. PubMed ID: 25708587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.
    Spinler SA; Cziraky MJ
    Ann Pharmacother; 1994 Mar; 28(3):343-51. PubMed ID: 8193425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
    Kimak E; Solski J
    Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and possible biological roles of Lp(a).
    Karmansky I; Gruener N
    Clin Biochem; 1994 Jun; 27(3):151-62. PubMed ID: 7923754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LP (a) lipoprotein: a new independent risk factor for atherogenesis].
    Davidoff P
    Rev Med Chil; 1991 Jan; 119(1):64-8. PubMed ID: 1840458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipoprotein (a): a new cardiovascular risk factor].
    Herbaut C
    Rev Med Brux; 1991 May; 12(5):167-72. PubMed ID: 1829265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current approaches to the diagnosis and correction of atherogenic dyslipoproteinemia].
    Oganov RG; Perova NV
    Kardiologiia; 1989 Oct; 29(10):15-22. PubMed ID: 2615152
    [No Abstract]   [Full Text] [Related]  

  • 39. Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.
    Gurakar A; Hoeg JM; Kostner G; Papadopoulos NM; Brewer HB
    Atherosclerosis; 1985 Nov; 57(2-3):293-301. PubMed ID: 2935163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of and treatment options for increased lipoprotein(a)].
    Zsíros N; Paragh G; Harangi M
    Orv Hetil; 2014 Apr; 155(16):607-14. PubMed ID: 24733102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.